Abstract
In the era of effective systemic therapy, the decision on whether or not to recommend post-operative adjuvant radiotherapy for intermediate risk breast cancer remains a point of discussion in many multidisciplinary tumour board meetings. Variations in advice regarding post-mastectomy radiotherapy have been demonstrated within the context of guideline-based practice [1]. A recent survey of nodal irradiation policy in European Organisation for Research and Treatment of Cancer (EORTC) centres also demonstrated a wide variation in practice [2].

This publication has 16 references indexed in Scilit: